BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36805688)

  • 1. Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell.
    Liu X; Guo C; Leng T; Fan Z; Mai J; Chen J; Xu J; Li Q; Jiang B; Sai K; Yang W; Gu J; Wang J; Sun S; Chen Z; Zhong Y; Liang X; Chen C; Cai J; Lin Y; Liang J; Hu J; Yan G; Zhu W; Yin W
    Cell Death Dis; 2023 Feb; 14(2):142. PubMed ID: 36805688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells.
    Karmodiya K; Krebs AR; Oulad-Abdelghani M; Kimura H; Tora L
    BMC Genomics; 2012 Aug; 13():424. PubMed ID: 22920947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.
    Qiao Y; Wang R; Yang X; Tang K; Jing N
    J Biol Chem; 2015 Jan; 290(4):2508-20. PubMed ID: 25519907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
    Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
    Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethylene induces combinatorial effects of histone H3 acetylation in gene expression in Arabidopsis.
    Wang L; Zhang F; Rode S; Chin KK; Ko EE; Kim J; Iyer VR; Qiao H
    BMC Genomics; 2017 Jul; 18(1):538. PubMed ID: 28716006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Mechanism Study on Histone Acetylation Activating Glioblastoma-derived Neurotrophic Factor Transcription].
    Wang JC; Quan XY; Peng DT; Hu GC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 50(5):643-648. PubMed ID: 31762231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance.
    Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI
    Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors.
    Ebrahimi A; Schittenhelm J; Honegger J; Schluesener H
    J Neurosurg; 2013 Dec; 119(6):1424-31. PubMed ID: 24116725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.
    Hezroni H; Tzchori I; Davidi A; Mattout A; Biran A; Nissim-Rafinia M; Westphal H; Meshorer E
    Nucleus; 2011; 2(4):300-9. PubMed ID: 21941115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni.
    Anderson L; Gomes MR; daSilva LF; Pereira ADSA; Mourão MM; Romier C; Pierce R; Verjovski-Almeida S
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005539. PubMed ID: 28406899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas.
    Hervás-Corpión I; Navarro-Calvo J; Martín-Climent P; Iriarte-Gahete M; Geribaldi-Doldán N; Castro C; Valor LM
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Singh MM; Manton CA; Bhat KP; Tsai WW; Aldape K; Barton MC; Chandra J
    Neuro Oncol; 2011 Aug; 13(8):894-903. PubMed ID: 21653597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
    Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G
    Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression.
    Fang YC; Chan L; Liou JP; Tu YK; Lai MJ; Chen CI; Vidyanti AN; Lee HY; Hu CJ
    J Cell Mol Med; 2020 Jun; 24(12):6966-6977. PubMed ID: 32374084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live imaging of H3K9 acetylation in plant cells.
    Kurita K; Sakamoto T; Yagi N; Sakamoto Y; Ito A; Nishino N; Sako K; Yoshida M; Kimura H; Seki M; Matsunaga S
    Sci Rep; 2017 Apr; 7():45894. PubMed ID: 28418019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H3K9 acetylation level modulates gene expression and may affect parasite growth in human malaria parasite Plasmodium falciparum.
    Srivastava S; Bhowmick K; Chatterjee S; Basha J; Kundu TK; Dhar SK
    FEBS J; 2014 Dec; 281(23):5265-78. PubMed ID: 25252094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.